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Abstract 
 
Minnesota is home to the largest population of Somalis in the United States (US). The 
2011 United States Census Bureau estimates that there are more than 32,000 individuals of 
Somali origin [1, 2], and many believe there is a significant underestimation of this number. 
Somalis originate from a distinct geographic region in East Africa, and have obvious similarities 
in physical features suggesting relative genetic homogeneity.  In contrast, most African 
Americans descend from various areas in Africa, and have experienced significant intermingling 
amongst themselves and with other populations rendering this population less homogeneous. 
Thus, not surprisingly, diabetes may differ between Somalis and other African Americans.  
Type 1 diabetes (T1D) is an autoimmune disease of heterogeneous etiology [3-5]. Carrying 
specific human leukocyte antigen (HLA) alleles determines an individual’s genetic risk for 
developing T1D. It has been established that these alleles may differ between populations [3, 6]. 
This dissertation describes some of the clinical characteristics, diabetes autoantibody and HLA 
allele profiles, and explores cultural beliefs related to diabetes in Somali children with T1D who 
live in the Twin Cities, Minnesota. These studies have led to two papers, which have been 
submitted for peer-reviewed publication. 
 
My primary project, describes the immune and genetic basis of T1D in a group of Somali 
children in the Twin Cities, Minnesota by determining human leukocyte antigen (HLA) alleles 
and diabetes autoantibodies. Twenty-seven Somali children ≤19 years treated for T1D at the 
University of Minnesota and Children’s Hospitals and Clinics of Minnesota from January 1st, 
2012 to January 31st, 2014, participated. Venous blood samples for HLA alleles, and diabetes 
autoantibodies (GAD65, islet antibodies, insulin antibodies and ZnT8) were obtained. In these 27 
children, the most common HLA phenotype was DR3. Strikingly, 92% of subjects carried this 
phenotype (allele frequency 63%). Another common genotype was DR13 (27%, allele frequency 
14%). There was a relatively low frequency of DR4 (15%, allele frequency 8%). This genetic 
pattern is very different from that of Caucasians or African Americans. All 27 participants had 
positive elevation of at least one diabetes autoantibody confirming that this is autoimmune 
diabetes. GAD65 antibodies were found in 56% of subjects, IA-2 in 33%, and ZnT8 in 22%. 
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My second project was a cross-sectional study that describes cultural beliefs related to 
diabetes in Minnesota Somali children with T1D, and compares their diabetes control to that of 
non-Somali children with T1D. Demographic and clinical data were collected by history and from 
medical records of Somali children ≤19 years with T1D followed at the University of Minnesota 
Children’s Hospital and Children’s Hospitals and Clinics of Minnesota. A survey was 
administered to parents of all participants and to children aged ≥12 years. Twenty-five Somali 
children participated, with 24 parent-child pairs (2 siblings). In general, diabetes was well 
accepted. Seventy-one percent of parents indicated the child was “the same as before” other than 
having to do diabetes cares. Families were coping well, and the child was not treated differently 
than siblings. Performance of routine medical cares was described as the hardest part about having 
diabetes, but this was not related to conflicts with traditional culture or religion. One notable 
exception was difficulty performing carbohydrate counting on Somali foods. Our education 
materials were not helpful when it came to the traditional Somali diet. Respondents                  
were appreciative of the education provided by the diabetes team. Less than 10% used herbal 
supplements in addition to insulin. Mean HbA1c in Somali children was higher than the overall 
pediatric clinic average, 9.5±1.6% vs 8.8±1.6 (p =0.01). The difference was largely due to 
adolescent patients. 
 
These two studies suggest that autoantibody and HLA profiles of Somali children with 
diabetes are consistent with autoimmune T1D, and that their HLA profile is unique compared to 
African Americans with T1D. The data also highlight that the majority of Somali families cope 
well with diabetes, and that glycemic control in adolescents is worse than that of non-Somali 
peers. 
Findings from this study beg the question of whether differences in diabetes between 
Somali children and their non-Somali peers is merely a result of these differences in HLA alleles, 
or whether other factors influence glycemic control in this population. Data from this study will 
be used to target diabetes education and to provide culture-specific educational resources to 
improve the experience of living with this chronic condition. 
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Chapter One: Introduction 
 
A large number of Somalis fled the civil war in Somalia, in the last two 
decades, seeking refuge in several parts of the globe such as East Africa, Europe, 
the United States (US), and Canada, and changing the demographic profiles of the 
hosting countries [7]. The US state of Minnesota (MN), while not an intuitive 
destination choice for people accustomed to a desert climate, is known for a low 
unemployment rate, a strong social welfare system, and religious tolerance. A 
small group of Somali refugees was initially assigned to live in Minnesota by the 
US State Department working with local relief agencies; friends and relatives 
soon followed when word about the favorable job market in Minnesota had spread 
[8]. Minnesota now has the largest number of Somali immigrants in the US, 
estimated at 32,000 individuals, a figure thought to be an under estimation [1] [9]. 
I had first developed interest in studying diabetes in the Somali population during 
my pediatric endocrinology fellowship training at the University of Minnesota, 
when I noticed in my clinical practice that relatively large numbers of Somali 
children have type 1 diabetes (T1D), an observation shared by pediatric 
endocrinologists in the three main practice groups that treat pediatric diabetes in 
the Twin Cities, MN. This sparked my interest in looking for genetic risk factors 
in Somalis. Surprisingly, little has been published about diabetes in this 
population. Therefore, one of the aims of the work described in this dissertation 
was to better describe the genetic and autoimmune characteristics of diabetes in 
Somali children, and to shed light on the culturally-specific aspects related to 
having diabetes in this community. 
 
T1D affects approximately 1 in 400-600 children in the US, and the 
incidence is increasing [10, 11].  Its etiology is multifactorial, with genetic, 
immunologic and environmental components. Several genes have been described 
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in association with T1D, however, human leukocyte antigen (HLA) class II 
genes, located on chromosome 6, are by far the main genetic determinants of an 
individual’s risk for developing T1D [12, 13]. Each individual carries a pair of 
alleles (i.e. copies of a gene). The risk of T1D is related to specific human 
leukocyte antigen (HLA) alleles which may differ between populations 4, 8. 
Certain HLA alleles confer greater risk, such as DR3 (HLA-DRB1*03) or DR4 
( HLA-DRB1*04) alleles with DQ8 ( DQB1*03:02), while others are protective 
(DQB1*0602) [4, 14]. 
Detecting unique HLA allele profiles in Somali children with T1D could 
help explain whether their relatively high rate of T1D is due to –at least in part- to 
carrying high-risk HLA alleles. These data could potentially be used in risk 
assessment for T1D. 
 
Unfortunately, few data from Somalia describing the HLA types of 
children with T1D exist. In a small Finnish study by Oilinki et al, HLA analysis 
of 12 young Somali children with diabetes showed a high frequency of DR3, 
high frequencies of DR13 and DR1, and no DR4 [15]. This deferred from the 
typical T1D profile in Finland, with DR4 predominance.  Interestingly, the 
prevalence of T1D in Somali children was equal to that of all Finnish children, 
generally considered the highest in the world [15]. 
 
HLA type confers genetic risk. Once autoimmune destruction of beta cells 
begins, autoantibodies can be detected in the blood (long before blood glucose 
abnormalities appear). Autoantibodies are not considered to be agents of beta cell 
destruction, but simply immunologic markers. These include: glutamic acid 
decarboxylase (GAD65) antibodies, insulin autoantibodies (IAA), islet cell 
antibodies (ICA), insulinoma antigen 2 antibodies (IA-2, also known as ICA512), 
and zinc transporter 8 (ZnT8) antibodies [4]. The presence of positive 
autoantibodies supports a diagnosis of T1D. Similar to the Finnish study by 
Oilinki et al, where 67% of 12 Somali children were positive, O’Connor et al 
reported in their study involving 60 East African immigrants (Kenya, Uganda, 
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Ethiopia, Eritrea, and Somalia), that nearly 66% of immigrant children tested 
positive for at least one diabetes autoantibody type within 1 month of diagnosis of 
T1D [16]. GAD65 was the most common at 62.5%, followed by IAA (34.6%), 
IA-2 (25%) and ICA (14.3%)[16]. The Finnish study by Oilinki et al reported that 
57% had ICA, 50% had GAD65, 33% had IA-2, and 33% had ZnT8 antibodies 
[15]. 
 
This dissertation describes HLA types and diabetes autoantibodies in a 
larger group of Somali children with T1D than has ever been published in the 
medical literature. 
Proper diabetes control is crucial to minimize risk for potential future 
complications [17]. Children from ethnic minorities are known to have worse 
diabetes control than non-minority children [15, 18, 19]. Studies of adult Somali 
patients with type 2 diabetes (T2D) have shown worse glycemic control compared 
to non-Somalis [20]. Similarly, glycemic control in 15 Somali children in a 
Finnish study was higher than non-Somali children, with  a mean HbA1c of 
9.3±2.2% compared to 8.3±1.5%, respectively (p<0.001) [15]. Data from the 
Diabetes Control and Complications Trial (DCCT) indicate that 5-7 years of poor 
glycemic control, even during adolescence and young adulthood, results in an 
increased risk for microvascular and macrovascular complications in the 
subsequent 6-10 year period [21]. Thus, in this dissertation, glycemic control in 
Somali children with T1D is compared to that of their non-Somali peers with 
T1D followed in the pediatric diabetes clinic at the University of Minnesota 
(UMN) in order to gauge their future risk. 
 
It has been shown that cultural factors affect diabetes management in 
immigrant populations [22]. Understanding the specific cultural views towards 
diabetes, the perception of this condition in the Somali community, and attitudes 
towards treatment with medications versus folk/spiritual medicine, has the 
potential to significantly influence outcomes through partnership and compliance 
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with management. This study tapped into this aspect through developing and 
administering a survey from which responses could be used to customize and 
target education, an integral part of diabetes management, to address myths and 
common misconceptions, develop educational tools that are population-relevant, 
practical and culturally-sensitive, and to consolidate trust in the medical team, and 
improve adherence to management. 
 
This dissertation includes two submitted manuscripts. The first describes the 
HLA types and diabetes autoantibody status of a group of Somali children with 
T1D, while the second compares diabetes control in a group of Somali children 
with T1D to non-Somali children with T1D who are followed in the same clinic, 
and describes their cultural beliefs in relation to diabetes. 
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Chapter Two: Predominance of DR3 in Somali Children with 
Type 1 Diabetes in the Twin Cities, Minnesota 
Muna Sunni MBBCh; Janelle A. Noble, PhD; Liping Yu MD; Abdirahman M Dhunkal BA; Melena D. 
Bellin MD; MS; Brandon Nathan MD; Jennifer Kyllo MD; M. Jennifer Abuzzahab MD; Peter A. Gottlieb 
MD; Sunanda Babu PhD, MBA; Taylor Armstrong BS; Antoinette Moran, MD 
 
Summary 
 
 
Background: Minnesota is home to the largest Somali population in the US, and pediatric 
diabetes teams are seeing increasing numbers of Somali children with diabetes. 
 
Objective: To assess the immune and genetic basis of type 1 diabetes in Somali children in the 
Twin Cities, Minnesota. 
 
Methods: Twenty-seven Somali children ≤19 years treated for diabetes at the University of 
Minnesota Children’s Hospital and Children's Hospitals and Clinics of Minnesota underwent 
analysis of HLA alleles (n=26) and diabetes autoantibodies (GAD65, mIAA/IA, IA-2, ZnT8; 
n=27). Anti-transglutaminase antibodies (TG) for celiac disease were also measured. 
 
Results: In Somali children aged 12±5 years (33% female, disease duration 4±3 years), the most 
common HLA phenotype was DR3 (92% of subjects, allele frequency 63%), followed by DR13 
(27%, allele frequency 14%). There was a relatively low frequency of DR4 (15%, allele frequency 
8%). All 27 participants had positive elevation of at least one diabetes autoantibody.                  
All were on insulin, and insulin antibodies were positive in 93%. Excluding insulin antibodies, 19 
(70%) were positive for at least one other diabetes autoantibody; 37% had 1 autoantibody, 22% 
had 2, and 11% had 3. GAD65 antibodies were found in 56% of subjects, IA-2 in 33%, and ZnT8 
in 22%. Three (11%) were TG positive. 
 
6 
 
Conclusion: The autoantibody and HLA profiles of Somali children with diabetes are consistent 
with autoimmune type 1 diabetes (T1D). Their HLA profile is unique with an exceptionally high 
prevalence of DR3 alleles and relative paucity of DR4 alleles compared to African Americans 
with T1D. 
 
Background 
 
 
The East African coastal country of Somalia has experienced more than two decades of 
brutal civil war. Since the early 1990’s, refugees have settled in other East African countries, 
Europe, Canada and the United States (US). A small group of Somali refugees was initially 
assigned to live in Minnesota by the US State Department working with local relief agencies; 
friends and relatives soon followed when word about the favorable job market and religious 
tolerance in Minnesota spread [23]. Minnesota now has the largest population of Somalis in the 
US, with the majority of immigrants living in the adjoining cities of Minneapolis and St. Paul 
(“the Twin Cities”) [2]. The 2011 United States Census Bureau estimates that there are more than 
32,000 people of Somali ancestry in Minnesota, including both those born in Somalia and their 
descendants [2], though this is widely believed to be an underestimation. 
 
Pediatric endocrinologists in the Twin Cities have observed relatively high numbers of 
Somali patients with type 1 diabetes (T1D). Given the paucity of information in the literature 
describing the genetic and autoimmune profiles of T1D in Somalis, the following study was 
undertaken in Somali children to evaluate the autoantibody profile and HLA genotypes typically 
associated with T1D. We hypothesized that this population might have a unique HLA phenotype 
compared to other ethnic populations in the United States. 
 
Research Design and Methods 
 
 
Subjects 
Somali children ≤19 years with T1D seen in pediatric diabetes clinics at the University of 
Minnesota Children’s Hospital (UMN) from January 1st, 2012 to January 31st, 2014 and at 
Children’s Hospitals and Clinics of Minnesota (CHCM) from January 1, 2013- October 31, 2013 
were invited to participate. Peripheral blood samples were collected and serum for antibodies and 
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buffy coats for HLA were frozen and sent for analysis to the Eisenbarth Laboratory at the Barbara 
Davis Center for Childhood Diabetes (BDC, Denver, Colorado). All participants gave informed 
consent/assent using an IRB approved protocol with the assistance of a Somali interpreter as 
needed, and consent forms were provided in English and in Somali based on participants’ 
preference. 
Comparison data from African American pediatric patients with T1D were obtained from 
new-onset diabetes studies and population studies collected at BDC [24-27] and from published 
data [28]. The frequency of high risk T1D alleles in the Minnesota Somali cohort was compared to 
12 Somali children with T1D in Finland [15], 27 African American children with T1D at the 
Barbara Davis Center (BDC) [27], and a large population of African Americans (n=772) with 
T1D. 
 
Analysis 
The Eisenbarth Laboratory serves as the autoantibody/HLA reference laboratory for several 
large national studies including Type 1 Diabetes TrialNet and the Immune Tolerance Network. 
Insulin autoantibodies/antibodies (mIAA/IA) [29] were measured by radioimmunoassay, and islet 
antigen 2 (IA-2) [30], glutamic acid decarboxylase (GAD65) [30], and zinc transporter 8 (ZnT8) 
[25, 26] autoantibodies were measured by radioimmunoassay utilizing in vitro 
transcribed/translated proteins. Anti-transglutaminase antibodies (TG) for celiac disease were 
measured by radioimmunoassay. HLA Class II DRB1, DQA1 and DQB1 alleles were determined 
using luminex xMAP technology (Luminex, Austin, TX). SSO microspheres used for HLA allele 
typing were obtained from One Lambda, Inc., Canoga Park, CA. 
 
Results 
 
Subjects 
At UMN, 22 Somali children and youth with T1D were followed in pediatric diabetes clinic 
during the study period, twenty of whom participated. One of the 2 non-participating patients was 
excluded because of a history of a donor-unrelated cord blood transplant for aplastic anemia and a 
recent history of multiple blood transfusions. The second non-participant was a female who was 
lost to follow up. An additional 5 subjects were recruited from CHCM, from about 50 Somali 
children and youth who were seen in diabetes clinic during the study period. All subjects were on 
basal-bolus insulin therapy either by multiple daily injections or by insulin pump. 
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Table 2.1.  Subject Characteristics. 
Patient Age Sex Duration Age T1D Birth BMI Somali Clan  
No. (yr)  T1D (yrs) Onset (yr) Country z-score Mother Father 
1 13 F 9.3 3 US 1.15 Ogaadeen Ogaadeen 
2 16 F 5.3 11 US 1.68 Daarood Daarood 
3 19 M 3.6 15 Ethiopia -0.86 Isaaq Ciise (Dir) 
4 18 M 7 11 Kenya -1.98 Hawiye Hawiye 
5 10 M 7.2 3 US 0.82 -- -- 
6 12 M 5.3 6 US -0.54 Hawiye Hawiye 
7 15 M 2.4 13 US -0.10 Majeerteen Majeerteen 
8 2 M 0.7 1 US 0.56 -- -- 
9 17 M 2.5 14 US 1.43 Dir Daarood 
10 7 F 2.3 5 US 0.88 Slaban (Suleman) 
(Hawiye) 
Ogaadeen 
11 5 F 1 4 US 0.41 Ogaadeen Ogaadeen 
12 16 M 4 12 US 1.02 Digil(Tumi) Majeerteen 
13 3 M 1.3 2 US 1.22 Mejeerteen Majeerteen 
14 15 M 4 11 US -2.56 Hawiye Hawiye 
15 15 M 13 3 US 1.06 Majeerteen Majeerteen 
16 10 F 1.9 8 US 0.94 Hawiye Hawiye 
17 10 F 3.9 6 US 1.26 Warsangali Warsangali 
18 13 M 6.4 7 US 1.55 Ogaadeen Ogaadeen 
19 8 F 3.1 4 US 0.52 -- -- 
20 17 F 6.6 10 Kenya 0.19 -- -- 
21 8 M 2.5 5 US -1.53 Warsangali Air(Hawiye 
22 11 M 1 10 US 0.9 -- -- 
23 3 M 2.6 0.5 US 0.2 Gudarbiise (Dir) Ciise (Dir) 
24 13 M 0.15 12 US 1.15 Ogaadeen Ogaadeen 
25 17 M 10.9 6 Kenya 0.23 Ogaadeen Majeerteen 
26 11 F 0.5 10 US 1.57 Majeerteen Majeerteen 
27 3 M 2.3 1 US 1.16 Ogaadeen Ogaadeen 
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Subject characteristics are summarized in Table 2.1. Mean age at time of enrollment was 
12.3±5.0 years old with a mean age at onset of diabetes of 7.0±4.4 years. Sixty-seven percent 
were male.  Subjects were well nourished, with a BMI z-score of 0.46±1.1. All but 4 participants 
(85%) were born in the US. The 4 non-US-born participants were born in Kenya (n=3) and 
Ethiopia (n=1). The majority of patients participating in this study were from the Daarood clan: 
16 of them (59%) had at least one parent from the Daarood clan or one of its subclans 
(Majeerteen, Ogaadeen, and Warsangali). 
 
Autoantibody Profiles 
All 27 patients had positive titers reflecting elevation of at least one diabetes autoantibody 
(Table 2.2). Insulin administration itself can induce insulin antibodies and, predictably, insulin 
autoantibodies/antibodies (mIAA/IA) were positive in 93% (n=25); the two subjects without 
mIAA/IA were positive for other diabetes autoantibodies.  Excluding insulin antibodies, 19 of 27 
(70%) participants were positive for at least one diabetes autoantibody; 37% (n=10) of subjects 
had 1 autoantibody, 22% (n=6) had 2, and 11% (n=3) had 3. GAD65 antibodies were found in 
56% of subjects, IA-2 in 33%, and ZnT8 in 22%. Thus, the autoantibody profiles in these patients 
were consistent with autoimmune type 1 diabetes. 
 
Anti-transglutaminase (TG) antibodies (positive in autoimmune celiac disease which is 
found in about 3% of diabetes) were positive in 3 participants (11%). One had biopsy-proven 
celiac disease but was having difficulty following a gluten-free diet (subject #3), while the other 
two had not been previously identified as potentially having celiac disease. 
 
HLA Typing 
HLA results are depicted in Table 2.2.  Ninety-two percent of participants had at least one 
DR3 allele, and 9 subjects (35%) were DR3 homozygous. After DR3, the most common DR 
phenotype was DR13, with 7 (27%) subjects carrying at least 1 DR13 allele. Only 4 (15%) 
subjects had at least one DR4 allele, and none were DR4 homozygous. Three of these subjects 
(12%) were DR3/DR4. Two subjects (8%) carried at least one DR1 allele and one was 
homozygous. 
 
Table 2.3 compares the Minnesota Somali pediatric diabetes population to other 
populations. A group of 12 Finnish Somali children with diabetes also demonstrated a relatively 
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high allele frequency of DR3 (38% vs 63% in our population), as well as prominence of DR13 
and a relatively low frequency of DR4 alleles. In contrast, the African American T1D patients 
studied at BDC had higher DR13 (37%), followed by DR3 (33%) and DR4 (26%) phenotype 
frequencies. Similarly, in the larger cohort of US African American children, DR3 haplotype 
frequency was lower than in our Somali population (26%). 
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Table 2.2.  HLA type, diabetes autoantibody titers, and celiac autoantibody titers. These samples were 
analyzed by the lunimex specific oligonucleotide (SSO) method, which is able to distinguish between more 
alleles than the previous method of Dynal sequence SSO: *would be listed as DQA1*0301 by Dynal, 
**would be listed as DQB*0201 by Dynal. Normal cut-off values for autoantibody titers are GAD65=20, IA- 
2=5, mIAA/IA=0.01, ZnT8=0.02, TG=0.05. Grey boxes indicate positive antibody titers. 
 
 
HLA Haplotypes Diabetes Autoantibodies 
 
Pt 
 
1 
DR 
 
DR3/ DR1 
DRB_1 
 
03:01 
DQA1_1 
 
05:01 
DQB1_1 
 
02:01 
DRB_2 
 
01:02 
DQA1_2 
 
01:01 
DQB1_2 
 
05:01 
GAD65 IA-2 mIA ZnT8 
 
0.006 
TG 
 
0.004 
           0.008 0.005 
           0.005 0.259 
           -0.001 0.003 
           0.004 0.008 
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DR3/ DR3 
 
 
03:01 
 
 
05:01 
 
 
02:01 
 
 
03:01 
 
 
05:01 
 
 
02:01 
   0.011 0.014 
8 DR3/ DR3 03:01 05:01 02:01 03:01 05:01 02:01      
9 DR3/ DR3 03:01 05:01 02:01 03:01 05:01 02:01      
10 DR3/ DR3 03:01 05:01 02:01 0301 05:01 02:01 17 0 0.129 0.002 0.002 
  
267 
 
0 
 
0.097 
 
2 DR3/ DR4 03:01 05:01 02:01 04:01 03:02* 03:02 0 23 0.709 
3 DR3/ DR4 03:01 05:01 02:01 04:05 03:02* 02:02** 25 0 0.036 
4 DR3/DR4 03:01 05:01 02:01 04:05 03:03 03:02 0 17 0.022 
5 DR3/ DR3 03:01 05:01 02:01 03:01 05:01 02:01 11 4 0.087 
6 DR3/ DR3 03:01 05:01 02:01 03:01 05:01 02:01 7 2 0.681 
 182 429 0.436 0.142 0.003 
435 3 0.003 0.001 0.017 
541 0 0.169 0.161 0.011 
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11 DR3/DR3 03:01 05:01 02:01 03:01 05:01 02:01 29 0 0.597 -0.002 0.062 
12 DR3/DR3 03:01 05:01 02:01 03:01 05:01 02:01 636 0 0.118 -0.002 -0.001 
13 DR3/DR3 03:01 05:01 02:01 03:01 05:01 02:01 162 0 0.366 0.011 -0.001 
14 DR3/DR13 03:01 05:01 02:01 13:02 01:02 06:09 0 14 0.052 0.001 -0.006 
15 DR3/DR13 03:01 05:01 02:01 13:02 01:02 06:04 0 1 0.045 0.007 -0.001 
16 DR3/DR13 03:01 05:01 02:01 13:02 01:02 06:04 903 78 0.051 0.234 0.012 
17 DR3/DR13 03:01 05:01 02:01 13:02 01:02 06:04 34 69 0.012 0.008 0.008 
18 DR3/DR13 03:01 05:01 02:01 13:02 01:02 06:04 2 0 0.546 0.007 -0.01 
19 DR3/DR13 03:01 05:01 02:01 13:02 01:02 06:04 22 2 0.139 0.001 0.005 
20 DR3/ DR8 03:01 05:01 02:01 08:04 05:01 03:01 122 1 0.334 0.012 0.154 
21 DR3/ DR8 03:01 05:01 02:01 08:04 05:01 03:01 6 1 0.649 0.008 0.009 
22 DR3/DR8 03:01 05:01 02:01 08:04 04:01 04:02 1 285 0.253 0.381 -0.001 
23 DR3/ DR9 03:01 05:01 02:01 09:01 03:02* 03:02 1090 0 4.369 0.006 0.004 
24 DR3/DR10 03:01 05:01 02:01 10:01 01:01 05:01 92 180 0.003 0.004 0.008 
25 DR4/DR13 04:05 03:01 02:02** 13:02 01:02 06:09 2 0 0.011 0.002 -0.01 
26 DR1/ DR1 01:02 01:01 05:01 01:02 01:01 05:01 428 387 0.012 0.075 0.016 
27 --- --- --- --- --- --- --- 7 0 0.278 0 0.013 
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Table 2.3. Comparison of high-risk DR alleles in 26 Minnesota Somali 
children with T1D (MN), 12 Finnish Somali children with T1D ([15]), 27 
African American children with T1D at the Barbara Davis Center (AA¹), and 
722 African American children with T1D from published data (AA²).  Data 
are presented as number within the population and (frequency within the 
population). 
 MN FINN AA¹ AA² 
DR3 phenotype 24/26 (92%) 7/12 (58%) 9/27 (33%) -- 
DR3 allele 33/52 (63%) 9/24 (38%) 12/54 (22%) 398/1544 (26%) 
DR3/DR3 9/26 (35%) 2/12 (17%) 3/27(11%) 69/772 (9%) 
 
DR4 phenotype 
 
4/26 (15%) 
 
2/12 (17%) 
 
7/27 (26%) 
 
-- 
DR4 allele 4/52 (8%) 3/24 (13%) 7/54 (13%) 350/1544 (23%) 
DR4/DR4 0/26 (0%) 1/12 (10%) 0/27 (0%) 18/772 (2%) 
DR4/DR3 3/26 (12%) 0/12 (0%) 3/27 (11%)  
 
DR13 phenotype 
 
7/26 (27%) 
 
4/12 (33%) 
 
10/27 (37%) 
 
-- 
DR13 allele 7/52 (14%) 4/24 (17%) 10/54 (19%) 70/1544 (5%) 
 
DR1 phenotype 
 
2/26 (8%) 
 
4/12 (33%) 
 
4/27 (15%) 
 
-- 
DR1 allele 3/52 (6%) 5/24 (21%) 5/54 (9%) 83/1544 (5%) 
 
DR9 phenotype 
 
1/26 (4%) 
 
0/12 (0%) 
 
4/27 (15%) 
 
-- 
DR9 allele 1/52 (2%) 0/24 (0%) 4/54 (7%) 142/1544 (9%) 
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Discussion 
 
 
Our analysis demonstrates that the autoantibody and HLA profiles of Somali children with 
diabetes are consistent with autoimmune type 1 diabetes. Their HLA profile is unique, however, 
with an exceptionally high prevalence of DR3 alleles, a high prevalence of DR13 and DR1 
alleles, and relative paucity of DR4 alleles compared to established profiles of US African 
American children. 
 
HLA DR3 and DR4 are well known to be associated with the highest risk for developing 
T1D [31], but the clear preponderance of DR3 in our Somali population is unusual. While DR3 
may indeed be a particularly high risk diabetes allele for Somalis, an alternative explanation is 
that DR3 may be common overall in Somali immigrants, whether or not diabetes is present, in 
what is likely a relatively inbred population. Somalis are organized into patrilineal clan 
groupings. These are very important social units, and clan associations have undoubtedly had a 
major influence on both exile and immigration patterns. No official information exists on the clan 
background of Minnesota’s Somalis, but over two-thirds of Somali patients participating in the 
current study (including the two who did not carry DR3 alleles) were from the Daarood clan. 
Currently, little information is available regarding the background HLA phenotype in the general 
Somali population. In a previous analysis of 76 Somalis living in England, HLA genotypes with 
the highest frequencies were DR13, DR17, DR8 and DR1; interestingly, DR3 was not identified 
[32]. The HLA pattern in the English cohort was felt to be more related to typical Arab HLA class 
I and class II antigens than to that of African populations. This conclusion was consistent         
with Y chromosome and mitochondrial DNA analyses demonstrating that Somalis are more 
closely related to Ethiopians, Sudanese, Egyptians, and North African Arabs than to other African 
populations [33, 34]. Another reason the Somali genotype may differ from that of African 
Americans is that the Somali community remains relatively ethnically homogeneous and lacks the 
significant genetic mixing that has occurred between African Americans and Caucasians since 
Africans were first brought to the Americas several centuries ago. 
 
Almost all of the Somali children with diabetes were born in the US which begs the 
question of whether the disease is triggered more often in a Western environment compared to 
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their native country. Unfortunately, the incidence and prevalence of pediatric diabetes has not 
been established in Somalia. Until the last few years, pediatric endocrinologists were rare in sub- 
Saharan Africa, and most clinics were not equipped to perform blood glucose testing. Children 
with diabetes usually died without ever receiving a correct diagnosis. Even when a diagnosis was 
made, insulin therapy was not reliably available and life expectancy was short, making accurate 
assessments of diabetes prevalence nearly impossible. A pediatric endocrinology fellowship 
training program in Kenya sponsored since 2008 by the European Society for Pediatric 
Endocrinology (ESPE) and the International Society for Pediatric and Adolescent Diabetes 
(ISPAD), has now trained dozens of African pediatric endocrinologists, creating a dramatic 
improvement in recognition of diabetes as a disease entity. This, together with greater 
accessibility of insulin (and to a lesser extent test strips) through international relief organizations 
such as Life for a Child and pharmaceutical company charitable programs, has significantly 
improved the situation for children with diabetes in Africa. With increased disease recognition 
and better care, the prevalence of childhood diabetes is rapidly increasing [35]. Unfortunately, 
these changes have not yet reached Somalia, where near total social disintegration exists due to 
decades of war. Until Somalia’s political situation stabilizes, accurate medical diagnoses data on 
the prevalence of childhood diabetes will remain elusive. 
 
Similar to Minnesota, Finland has also experienced a large Somali immigration. HLA 
analysis of 12 young diabetic patients was comparable with the Minnesota findings, with an 
unusually high frequency of DR3, high frequencies of DR13 and DR1, and low DR4. 
Interestingly, the prevalence of T1D in Somali children was equal to that of all Finnish children, 
generally considered the highest in the world. The total population of Somali children in 
Minnesota is estimated from census data to be about 17,000 children [36]. Most children with 
diabetes in Minnesota, even from the outlying areas, are seen by 4 pediatric endocrinology 
clinics in the  Twin Cities and Rochester. These 4 together report about 80 Somali T1D patients 
(personal communication).  If approximately 80 of 17,000 Somali children have diabetes, the 
estimated prevalence of diabetes in Somali children is about 1/250 children, which is higher than 
the  general population estimated prevalence of 1/400 to 1/500 children with diabetes in  
Minnesota [37, 38] and the US [38]. However, state census data probably underestimate the total 
number of Somalis in Minnesota and thus the true number is probably more similar to that of the 
general population. Further epidemiological studies are needed to generate a more accurate 
estimate of prevalence of T1D in Somali children in Minnesota. 
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Although our analysis describes the largest cohort of Somali children with T1D to date, a 
limitation of this study remains the relatively small subject number, which can lead to erroneous 
conclusions in genetic analyses. Nevertheless, it is reassuring that the Minnesota and Finnish 
studies largely agree with respect to HLA type. An additional limitation is the lack of genetic 
background information on the general Somali population; efforts are planned to perform HLA 
typing in non-diabetic Somalis in Minnesota. 
 
In conclusion, diabetes appears to be as common in Somali children as in the general US 
population, and is clearly autoimmune in origin. In contrast to African American populations, 
DR3 genotype appears to be particularly preponderant, and DR4 appears to be of less importance 
in Somalis with T1D. 
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Chapter Three: Understanding Cultural Beliefs in Families of 
Somali Children with Diabetes in Minnesota 
Muna Sunni, MBBCh; Mohamed Farah,BA; Christine Hardie, BA, Abdirahman M Dhunkal, BA; M. 
Jennifer Abuzzahab, MD; Jennifer H. Kyllo, MD; Melena D Bellin, MD, MS; Brandon Nathan, MD; 
Antoinette Moran, MD 
 
Summary 
 
 
Objective: Describe cultural beliefs related to diabetes in Minnesota Somali children with type 1 
diabetes (T1D), and compare their diabetes control to that of T1D non-Somali children. 
 
Methods: A cross-sectional study involving Somali children ≤19 years with T1D at the 
University of Minnesota Children’s Hospital and Children’s Hospitals and Clinics of Minnesota. 
A survey was administered to parents of all participants and to children aged ≥12 years. 
Demographic and clinical data were collected by history and from medical records. 
 
 
Results: Twenty-five Somali children participated, with 24 parent-child pairs (2 siblings). Mean 
participant age was 12.2±5.2 (36% female). Seventy-one percent of parents indicated the child 
was “the same as before” other than having to do diabetes cares. Families were coping well, and 
the child was not treated differently than siblings. Performance of routine medical cares was 
described as the hardest part about having diabetes, but this was not related to conflicts with 
traditional culture or religion. One notable exception was difficulty finding resources to help with 
performing carbohydrate counting on traditional Somali foods. Respondents were appreciative of 
the education provided by the diabetes team. Less than 10% used herbal supplements in addition 
to insulin. Mean HbA1c in Somali children was higher than the overall pediatric clinic average, 
9.5±1.6% vs 8.8±1.6 (p =0.01). The difference was largely due to adolescent patients. 
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Conclusion: The majority of Somali families cope well with diabetes and have a positive attitude 
towards diabetes education and the diabetes team. Glycemic control in adolescents is worse than 
that of non-Somali peers. There is a need for culture-specific dietary instruction materials. 
 
 
 
Background 
 
 
Successful management of a chronic disease such as T1D requires that patients and 
families perform complicated tasks multiple times a day. To do this, they must understand what 
should be done and why, accept that the tasks are necessary, and learn how to integrate these 
activities into everyday life. In immigrant populations, the social and religious aspects of their 
unique cultures can influence acceptance of these crucial components of chronic disease 
management [22]. Although healthcare workers may acknowledge the potential impact of culture 
and religion, a knowledge gap of how to best tailor education and management approaches to the 
needs of specific populations often exists. 
Minnesota is home to the largest Somali population in the US [1]. A reported 32,000 
Somalis live in the state, although this may be an underestimation [9]. The vast majority resettled 
in Minnesota in the 1990’s and early 2000’s as refugees fleeing the civil war that erupted in their 
home country of Somalia. This shift in the state population demography over the past decades is 
reflected in the diversity of patient ethnicities seeking health care. Childhood T1D has emerged as 
one of the challenging problems this population is facing in Minnesota and elsewhere [15]. 
Raising awareness among healthcare providers about the cultural nuances of Somalis and 
understanding their perception of disease, the difficulties they face, and their needs, may help in 
the development of culturally-appropriate plans for overcoming the hurdles confronting this 
population and provide them with a better patient experience and improved diabetes control [39, 
40]. This knowledge could facilitate bridging gaps between the Somali community and the 
healthcare system. Given the paucity of data describing the Somali community’s stance on 
modern medicine and its relation to their cultural and/or religious beliefs, we conducted a pilot 
survey of families of Somali children with T1D. The ultimate goal is to improve diabetes control 
in the Somali population, and provide a better patient experience in managing this chronic 
condition. 
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Study Design and Methods 
 
 
Participants 
Pediatric patients aged ≤19 years of Somali ancestry with T1D living in the greater 
Minneapolis-St. Paul-Bloomington metro area, Minnesota, followed at the University of 
Minnesota (UMN) Pediatric Diabetes Clinic and at Children’s Hospitals and Clinics of Minnesota 
(CHCM) were identified from January 1st, 2012- January 31st, 2014. Recruitment took place with 
the assistance of a Somali interpreter and an undergraduate Somali student at UMN.  
Demographic data were collected via history and the medical record, including birth place, place 
of diagnosis (US, Somalia, Kenyan or Ethiopian refugee camp, other) and percent of lifetime lived 
in the US. Clinical information obtained by history included family history of diabetes, date of 
diagnosis, number of hospitalizations for diabetic ketoacidosis, and number episodes of severe 
hypoglycemia (seizure, unconsciousness). Clinical information obtained from the electronic 
medical record included current insulin regimen, insulin dose, and most recent height and weight. 
Hemoglobin A1c (HbA1c) levels for each participant were averaged over the evaluation years; 
HbA1c values in the first 6 months following diabetes diagnosis were not included in analyses. 
Mean annual HbA1c value was calculated for the non-Somali pediatric diabetes clinic T1D 
patient population followed at UMN during the study years (n=351). The study was approved by 
the UMN and CHCM Institutional Review Boards. Written informed consent was obtained from 
parents/guardians (in English or Somali, based on participant preference) and assent from 
participating children through an interpreter. 
 
Surveys 
Members of the pediatric diabetes team together with a Somali interpreter constructed a 
survey containing open- and closed-ended questions examining cultural and religious beliefs 
related to diabetes. Questions for the survey were based on observations of parental concerns and 
or common misconceptions that had consistently emerged during diabetes clinic visits. Surveys 
were available both in English and Somali, depending on respondent preference. The parent(s) of 
each participant took the survey (19 mothers and 5 fathers). Children aged ≥12 years were asked 
to fill out the same survey as their parents. Eight of the 14 questions were multiple-choice with 
more than one answer, where respondents were asked to select all that applied. Additionally, each 
 
20 
 
of these questions had an option for “other”, allowing respondents to write their own response if 
none of the options seemed relevant. The remaining 6 questions were open-ended with no 
answers provided. 
Questions were filled out at the time of recruitment after informed consent was obtained with the 
assistance of a Somali interpreter, as needed. 
 
Statistical Analyses 
Data were analyzed using SAS version 9.3 (SAS Institute Inc., Cary, NC). Descriptive 
statistics are primarily presented as mean±standard deviation (SD). HbA1c averages were 
compared between patients of Somali origin who participated in the study and those of the overall 
T1D pediatric population in the UMN clinic using Student’s t-test. P-values <0.05 were 
considered statistically significant. 
Several questions in the survey allowed for more than one answer including multiple-choice 
questions. The proportion of participants who answered a question positively (or optimistically) 
versus the number who had a negative response to that question was determined among parents 
and children. For open-ended questions, results are displayed as frequency of each of the 
responses provided. 
 
 
 
Results 
 
 
Subjects 
Twenty-three children of Somali origin age ≤19 years were followed at UMN during the 
study period. Of these, 20 (87%) consented to participate in the study but two did not complete 
the surveys, leaving a total of 18 participants from UMN. Seven patients followed at CHCM were 
recruited to participate. Participant characteristics are detailed in Table 3.1. Four participants 
(16%) were born outside of the US in African refugee camps (1 in Ethiopia and 3 in Kenya). All 
but one, were diagnosed with T1D in the US (96%). Mean BMI percentile was 62±30% (range 6- 
>99%). Twelve percent (n=3) of participants were overweight (BMI ≥ 85th < 95th percentile) and 
1 participant was obese (BMI ≥95th percentile) for age and gender. 
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Table 3.1. Characteristics of 25 Somali children with T1D age 
 
≤19 years. * NA= Not available 
Variable Mean  SD or N (%) 
Age, yrs 12.2 ± 5.2 
Female gender 9 (36) 
Age at diagnosis, yrs 6.8 ± 4.4 
Duration of diabetes, yrs 5.3 ±  3.6 
US-born 21 (84) 
Percent of lifetime lived in US 91 ± 25 
Family history of diabetes (Yes/No/*NA) 21/3/1 
Prior DKA (Yes/No/*NA) 13/8/4 
Previous Severe hypoglycemia (Yes/No/*NA) 4/20/1 
Average insulin dose, unit/kg/day 0.75 ± 0.3 
Hemoglobin A1c, % 9.5 ± 1.6 
BMI, kg/m² 19.8 ± 3.7 
BMI z-score 0.47 ± 1.1 
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Survey Results 
Twenty-four surveys were completed by parents of 25 children, including 2 siblings. 
Twelve children who were ≥12 years old also participated. Some of the questions were left 
unanswered by participants. This was especially true for the open-ended questions. Overall, the 
survey responses indicated a positive and optimistic attitude about the impact of diabetes on the 
child and the family. They appreciated the information and education provided by the pediatric 
diabetes team (Table 3.2). 
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Table 3.2.  Summary of Survey Results. N=24 parent respondents (5 
fathers and 19 mothers) and 12 children age 12-19 years with diabetes. The 
survey included 8 multiple choice questions (with an option for "other" if 
none of the responses applied), and 6 free-response open-ended questions. 
Not all subjects answered all questions. 
 
Multiple Choice Questions 
Parents, 
N (%) 
Patients 
N (%) 
1.   What does having diabetes mean for your child now? 
Positive: child has to do diabetes cares 
but is otherwise the same as before 
17 (71) 8 (67) 
Negative: child is sick, has to stay home 7 (29) 4 (33) 
2.   How has the diagnosis of diabetes affected your child? 
Positive: no change 13 (57) 5 (45) 
Negative: perceives self as "sick", 
difficulty fitting in with peers, embarrassed 10 (43) 
6 (55) 
3.   What concerns do you have about your child's future? 
Positive: no concerns 13 (57) 6 (55) 
Negative: difficulty finding a partner or job, 
fertility,  future diabetes complications 10 (43) 
5 (45) 
4.   What impact does having a child with diabetes have on your family? 
Positive: no change, family copes well 19 (79) 10 (83) 
Negative: disrupts family life, hard on the 
other children in family, Mom feels guilty 5 (21) 
2 (17) 
5.   How do you treat your child with diabetes compared to your other children? 
Positive: no different except for 
diabetes specific cares 17 (71) 
8 (67) 
Negative: child is "fragile", different 
discipline compared to siblings 7 (29) 
4 (33) 
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6.  How do you think your Somali community perceives children with 
diabetes? 
Positive: Not any different from other 
children 14 (58) 
9 (75) 
Negative: disabled, sick, abnormal 10 (42) 3 (25) 
7.  Could your child's diabetes have been prevented? 
Positive: No, not sure 22 (92) 11 (92) 
Negative: Yes 2 (8) 1 (8) 
8.   What remedies have you used alongside insulin to treat diabetes? 
Positive: None, prayer 21 (91) 11 (92) 
Negative: Herbal supplements 2 (9) 1 (8) 
Open Ended Questions--Free responses, 
subjects may have more than 1 answer 
Parents, 
N 
Children, 
N 
9.  Why do you think your child got diabetes? 
Don't know 4 0 
God's will 4 2 
Exposure (environment or medications) 2 0 
Bad eating habits 1 2 
Illness or infection 1 1 
Got it from someone else 1 4 
Pancreas stopped working 0 1 
Parent "not there for child" 1 0 
10. What is the hardest part about having a child with diabetes? 
Nothing 1 1 
Counting carbs 1 0 
Checking glucose level and giving 
insulin on time 6 
4 
Managing sick days 0 1 
Lifestyle changes 3 4 
Worrying about child's health 1 2 
11. What part of your child's current treatment is hard to fit into your 
traditional culture or religion? 
None 9 9 
Difficulty with Ramadan 0 2 
Other people think it can be cured 1 0 
Eating Somali food 2 0 
Going to the doctor often 1 0 
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12. What has your medical team done for you/your child that has been 
helpful? 
Provided information/education 7 1 
Managed blood sugars and insulin 6 5 
Helped with lifetime struggle 1 3 
Group meeting with the family 1 0 
Learn the outcome of this study 1 0 
13. What do you wish your medical team would do to further help you/your 
child? 
Nothing, they already do everything 
they can 
 
2 
 
4 
Understand Somali diet 4 0 
Find a cure for diabetes 4 1 
Find a new treatment that tis not an 
injection 
 
1 
 
0 
Emotional support 2 1 
Continue to provide the best 
treatment, follow-up and education 
 
2 
 
2 
14. What would be helpful for the medical team to know about your culture 
and childhood diabetes? 
Nothing 2 3 
Concerns about fasting in the future 1 1 
Somali food-specific carb counting 2 3 
Female patients feel more comfortable 
with female providers 
 
1 
 
0 
Things that happen in life are God's 
will 
 
1 
 
0 
My child is not any different from 
other kids 
 
1 
 
0 
Diabetes in kids is not known to our 
community 
 
1 
 
0 
We trust the medical team 1 1 
Exercise and diet alone are sufficient 1 1 
Learning about diabetes resources 
available to our community 
 
0 
 
1 
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With regards to the effect of diabetes on the child, more than two-thirds of respondents 
indicated the child was “the same as before” other than having to do diabetes cares. However, in 
response to a separate question, 43% of parents and 55% of children reported that the child 
perceived him or herself as sick, had difficulty fitting in with peers, or was embarrassed by the 
disease. The most common concern expressed about the child’s future was risk of diabetes 
complications. 
Seventy-nine percent of parents and 83% of children felt the family was coping well with 
the diagnosis of diabetes, and for the most part reported that the child with diabetes was not 
treated differently than siblings. Performance of routine medical care such as counting 
carbohydrates, checking glucose levels, and giving insulin was described as the hardest part about 
having diabetes. 
Forty-two percent of parents and 25% of children had concerns about how the Somali 
community perceives children with diabetes. However, they mostly did not feel that diabetes 
treatment was hard to fit into their traditional culture or religion. One exception was difficulty 
performing carbohydrate counting on foods in the traditional Somali diet, which was mentioned 
several times. 
Almost all parents and children answered that T1D could not have been prevented, although 
some of the answers in the open-ended questions suggested that some of them suspected 
preventable etiologies such as contagious illness, diet, or that the parent was at fault. Less than 
10% used herbal supplements in addition to insulin, and these were primarily honey and garlic. 
 
Diabetes Management and Metabolic Control 
The majority of participants (67%) were on a regimen consisting of multiple daily 
injections with a long-acting basal insulin and a rapid-acting insulin analog. The remaining 
participants used an insulin pump. The average insulin dose was 0.75 ± 0.3 units/kg/day (range 
0.18-1.35). 
HbA1c data were normally distributed. The mean HbA1c in the total group was 9.5±1.6% 
(range 6.1-12.9%). In contrast, the HbA1c was 8.8±1.6% (range 5.2-15%) for non-Somali 
patients age ≤19 years (p =0.01) (Figure 3.1). 
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Figure 3.1. HbA1c levels in Somali and non-Somali patients with type 1 diabetes in the total 
cohort aged ≤19 years. 
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When analyzed by age group, amongst children <10 years of age there was no difference in 
HbA1c levels between the Somali children (n=7) and the clinic cohort (n= 59) (8.8±0.8% vs 
8.5±1.1% respectively; (p =0.4) (Figure 3.2). All 7 Somali children <10 years had an HbA1c 
above the ADA target goal [41] for age compared to 86% of the clinic population. 
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Figure 3.2. HbA1c levels in Somali and non-Somali patients with type 1 diabetes <10 years 
of age. 
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In contrast, the average HbA1c level in patients of Somali origin age 10-19 years was 
9.7±1.7% (n=18) which was significantly greater than the average HbA1c of 8.8±1.7% in their 
non-Somali peers (n=292, p =0.02) (Figure 3.3). Almost all (94%) Somali adolescent patients had 
an HbA1c above the ADA target threshold [41] for this age group compared to 80% of the clinic 
population. 
 
Two of the 3 Somali patients followed at the UM who chose not to participate reached their 
19th birthday during the study period and the mean age was 19.8 ±1.3 years for all 3 patients at 
the end of the study. In these non-participants, mean HbA1c was 8.6±3.1%. 
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Figure 3.3. HbA1c levels in Somali and non-Somali patients with type 1 diabetes 10-19 years 
of age. 
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Discussion 
 
To our knowledge, this is the first published report describing the cultural and religious 
beliefs of Somali parents and children towards pediatric T1D. This study suggests that Somalis are 
largely appreciative of the diabetes education and support they receive from the pediatric diabetes 
team. Families generally cope well with the diagnosis, and do not report stigmatization of          
the child with diabetes. However, diabetes control, especially among adolescents, is worse than 
that of their peers of non-Somali origin. 
Prior to the current wave of Somali immigrants, in the 1980’s and 1990’s the Minnesota 
medical system had the experience of working with a large influx of Southeast Asian immigrants, 
who became known for their distrust of the medical establishment and their reliance on traditional 
healers [42, 43]. In contrast, the latest group of immigrants to Minnesota, the Somalis, appear to 
be far more accepting of modern medicine. This may be at least in part explained by the common 
Somali religious belief that everything that happens is God’s will and is planned by God and, 
therefore, cannot be prevented. Similarly, this take on life may explain why a large portion of 
survey respondents stated they had no concerns about their child’s future. When parents were 
asked specifically about whether they felt finding a marriage partner or fertility would be a 
potential future problem for their child, the response was almost always “no”, especially when the 
child was a male. While these parents may truly not have these concerns, it is also possible that 
they are amongst the “silent worries” described (in a different context) by Pavlish et al as topics 
that cannot be talked about openly from a cultural standpoint [7]. 
Wallin et al conducted cross-cultural interviews on 19 Somali adults with type 2 diabetes 
living in Sweden to describe the daily life experiences of these patients, different gender 
perspectives, and the effect of diabetes on religious practices such fasting during the month of 
Ramadan [22]. For most of our Somali pediatric patients, Ramadan did not appear to be a major 
concern, since children are not expected to fast, and abstinence from fasting is permitted in 
individuals with a medical condition such as diabetes, where it could potentially place them at 
risk. 
The finding of worse glycemic control in Somali pediatric patients compared to non-Somali 
patients is consistent with data from Finland, where mean HbA1c among 15 Somali children with 
diabetes was 9.3±2.2% compared to 8.3±1.5% in non-Somali children (p<0.001) [15]. Similarly, 
studies of adult Somali patients with type 2 diabetes have shown worse glycemic control 
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compared to non-Somalis [20]. In our cohort, the poorer glycemic control was largely confined to 
adolescent patients. While adolescents, in general, tend to experience worse glycemic control than 
younger children [44], immigrant youth may face additional challenges as they struggle with the 
normal adolescent task of fitting in with their peers. Socioeconomic factors may also play a role 
in poor diabetes control in Somali adolescents.  Children from ethnic minorities are known to 
have worse diabetes control than non-minority children [15, 18, 19]. More than half of our study 
participants did not provide specific socioeconomic data, so it was not possible to assess its effect 
in the current study. However, the majority of these subjects receive medical assistance. Other 
issues that are immigrant-specific that need to be explored are the literacy levels of the parents, 
the general stresses of cultural assimilation, and cultural issues surrounding diet. Anecdotal 
clinical experience suggests that Somali parents, who may have experienced food insecurity 
during their lives, are reluctant to limit food or beverage intake in their children. More study is 
necessary to further determine the root causes for these differences in overall diabetes control. 
One area the survey identified that warrants further attention is the difficulty that patients 
and parents experience in calculating carbohydrate content of traditional Somali food for the 
purpose of insulin adjustment. The typical Somali diet is rich in carbohydrate and contains foods 
not often identified in Western carbohydrate counting books and charts. This problem is 
compounded by the fact that the medical team may not be familiar with these foods and thus is 
unable to provide appropriate advice. We are currently engaged in an effort to develop these 
materials. 
The primary limitation of this study is the small sample size. We will continue to follow these 
patients and new Somali patients entering our practice over time to gain a greater understanding 
of the challenges and successes they experience. The survey did not focus on difference in gender 
perspectives in relation to diabetes, but this is an important area for future research. Further, the 
survey used in this study was not validated; it was, however, developed to encompass the main 
concerns that had surfaced during clinical visits with patients and their families. The open-ended 
questions allowed for the opportunity to learn and embrace new ideas, concerns or 
misconceptions this survey did not address. 
In conclusion, while Somali parents and children cope well emotionally with the diagnosis 
of T1D and enjoy a trusting relationship with their health care team, diabetes control is poor in 
Somali adolescents. Lack of traditional dietary resources has emerged as one specific problem 
that can be better addressed. 
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Chapter Four: Conclusion 
 
Thesis conclusions 
 
The first paper demonstrates that diabetes is at least as common in Somali children as in the 
general US population, and it is clearly autoimmune in origin. In contrast to African Americans, 
DR3 genotype appears to be particularly preponderant, and DR4 is of minimal importance in 
Somalis with T1D. 
The second paper demonstrates that while Somali parents and children cope well 
emotionally with the diagnosis of T1D and enjoy a trusting relationship with their health care 
team, diabetes control is poor in Somali adolescents. Lack of traditional dietary resources has 
emerged as one specific problem that can be better addressed. 
 
 
Limitations 
 
The biggest limitation of this study is the small subject number, which can lead to 
erroneous conclusions in genetic analyses. Despite this, the findings largely agree with the 
findings of a small Finnish study. Enrollment is ongoing in an attempt to capture as many 
participants as possible so that the sample will be representative. 
An additional limitation is the lack of genetic background information on the general Somali 
population.  Efforts are in place to obtain HLA type information on non-diabetic Somalis in 
Minnesota. 
 
 
Future directions 
 
Describing HLA types in Somalis without diabetes 
Results from this work, showed that Somali children with T1D have an exceptionally 
higher frequency of DR3 alleles, a finding that is different from African Americans and 
Caucasians. I am currently obtaining DNA samples from members of the Somali Community 
who do not have diabetes, to determine whether DR3 differences are related to diabetes per se or 
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if they are merely a reflection of the genetic background of the Minnesota Somali population in 
general. 
 
Exploring potential contributors to poor glycemic control 
Through working with Somali children and adolescents with diabetes, it became evident 
that Somali adolescents have worse diabetes control than the rest of the T1D clinic population at 
UMN. 
Little is known about how differences in Somali families and communities might be 
influencing this discrepancy in diabetes control, therefore, I plan to understand and describe 
psychosocial, socioeconomic, cultural, familial or educational factors that might be preventing 
Somali adolescent patients with T1D from having optimal glycemic control. 
 
Establishing educational material 
The work described in this dissertation included developing a survey examining the cultural 
and religious beliefs related to diabetes in the Somali population. The goal was to use 
information from survey responses to identify common misconceptions, to develop educational 
tools that specifically target Somali patients and their families, and to provide resources that are 
culturally relevant and address concerns unique to this population. Interestingly, lack of resources 
for counting carbohydrates in traditional Somali foods emerged as an obstacle precluding 
adequate and accurate insulin dosing in these patients and ultimately affecting glycemic control. 
This has triggered an effort to develop specific Somali dietary resources. I am currently working 
on a University of Minnesota CTSI, Children's Hospitals and Clinics of Minnesota, & UMN 
Pediatric Department grant proposal to improve diabetes management in Somali children and 
adolescents in Minnesota, in response to an RFA designed to support collaborative research 
addressing important and unmet human child health issues in Minnesota. The project will involve 
development of video and picture-based educational materials (since many parents are illiterate), 
written materials in the Somali language, continuing work on a carbohydrate counting booklet 
which is specific for traditional Somali foods, and creation of support groups for parents of young 
Somali children with T1D. The ultimate goal is to improve delivery of effective diabetes 
education to this population in order to improve diabetes control. 
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